Prothena Stock Price (NASDAQ:PRTA)

Add to My Stocks
$54.89 $0.81 (1.5%) PRTA stock closing price Apr 25, 2017 (Closing)
25 APR 2017
amigobulls logo
PRTA hand_up
PRTA vs S&P 500
Closing Price: Apr 25, 2017
$54.89 ( 1.5%)
S&P 500
2388.6 ( 0.61%)
52 Week Price Range
1 Year Return: 14.84%
Q4 Growth*
Profitable ?
net image
2016 Q4 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Prothena Snapshot Video

11 5 2

PRTA Stock Details

Prev Close* : $54.08
Market Cap:
Day Low: $54
52 Week Low: $33.53
Open: $54.57
Volume: 269428
Day High: $55.31
52 Week High: $68.18

Latest Stock Market News

Latest Articles

Prothena News - From Partners

PRTA Stockcharts

View PRTA PE ratio, PS ratio stocks charts and compare with peers.
PRTA Chart
Note: Compare Prothena stock price history with the index and industry peers.

Prothena Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Prothena Financial Ratios

Receivables Turnover

PRTA Industry Peers

Company Price Change (%)
Ligand Pharma (LGND)108.93.78 (3.6%)
Axovant Sciences (AXON)23.090.59 (2.62%)
Roche Holdings (RHHBY)32.410.4 (1.25%)
Neuroderm (NDRM)28.350.9 (3.28%)
Voyager Therapeutics (VYGR)10.750.43 (4.17%)
Cynapsus Therapeutics (CYNA)40.480 (0%)
Intec Pharma (NTEC)5.550.05 (0.91%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Epizyme (EPZM)17.452.55 (17.11%)
Sangamo BioSciences (SGMO)4.750.45 (10.47%)
Fortress Biotech (FBIO)3.570.29 (8.84%)
Idera Pharma (IDRA)2.4350.19 (8.44%)
Achillion Pharma (ACHN)3.480.27 (8.41%)
Revance (RVNC)22.451.55 (7.42%)
Immunomedics (IMMU)5.440.36 (7.08%)
Top gainers from Medical-Biomed-Genetics industry
* As of Apr 26, 2017
CompanyPriceChange (%)
AKARI THERAPTC (AKTX)15.252.24 (12.81%)
The Medicines Company (MDCO)49.112.34 (4.55%)
Kindred Biosciences (KIN)6.850.3 (4.2%)
ALBIREO PHARMA (ALBO)21.610.37 (1.68%)
Repligen (RGEN)34.630.48 (1.37%)
Cara Therapeutics (CARA)16.390.22 (1.32%)
NOVELION THERAP (NVLN)10.090.12 (1.18%)
Top losers from Medical-Biomed-Genetics industry
* As of Apr 26, 2017

Prothena Corporation PLC Stock News - Partner Headlines

Prothena Financial Statements

income statement20162015201420132012
Net Sales Or Revenues1.05M1.6M50.85M0.67M2.65M
Net Income-160.1M-80.61M-7.15M-40.99M-41.41M
Total Operating Expense160.58M81.53M57.5M41.1M44.05M
view Prothena Corporation PLC income statement
balance sheet20162015201420132012
Total Assets459.97M385.23M304.11M182.41M129.28M
Total Liabilities94.57M24.56M14.22M9.14M2.79M
Shareholders Equity365.4M360.66M289.88M173.27M126.48M
view Prothena Corporation PLC balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities18.88M11.47M1.37M5.67M-7.22M
Net Cash From (Used By) Operating Activities-117.26M-62.45M-0.68M-32.09M-42.07M
Increase (Decrease) In Prop Plant And Equipment-16.64M-1.38M-0.49M-0.53M-1.3M
view Prothena Corporation PLC cashflow statement

Prothena Stock Message Board

Prothena stock lost 1.5 %, and the last close price as of 25 Apr, 2017 is 54.89 for PRTA stock. Stock price or share price can be used to find the total market value of a company. Prothena market cap stands at 2.05B as of 25 Apr, 2017. Prothena valuation can be guaged using various valuation metrics like the price to earnings ratio.

The terms stocks and shares mean the same thing. For Ex: Prothena stock price and Prothena share price mean the same thing. The volume number in Prothena stock quote data shows the number of shares traded. For Ex: 269428 Prothena shares were traded as of last trading day, as seen from Prothena stock chart. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. To check the historical stock price movement, all time high, and all time low of PRTA, view Prothena stock price history.